DK0883611T3 - Azolylpiperazinylphenyloxazolidinoner som antimikrobielle midler - Google Patents

Azolylpiperazinylphenyloxazolidinoner som antimikrobielle midler

Info

Publication number
DK0883611T3
DK0883611T3 DK97907574T DK97907574T DK0883611T3 DK 0883611 T3 DK0883611 T3 DK 0883611T3 DK 97907574 T DK97907574 T DK 97907574T DK 97907574 T DK97907574 T DK 97907574T DK 0883611 T3 DK0883611 T3 DK 0883611T3
Authority
DK
Denmark
Prior art keywords
carbon
nitrogen
image
azolylpiperazinylphenyloxazolidinones
antimicrobial agents
Prior art date
Application number
DK97907574T
Other languages
Danish (da)
English (en)
Inventor
Robert C Gadwood
Michael R Barbachyn
Dana S Toops
Herman W Smith
Valerie A Vaillancourt
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of DK0883611T3 publication Critical patent/DK0883611T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/26—Oxygen atoms attached in position 2 with hetero atoms or acyl radicals directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK97907574T 1996-02-26 1997-02-18 Azolylpiperazinylphenyloxazolidinoner som antimikrobielle midler DK0883611T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1231696P 1996-02-26 1996-02-26
PCT/US1997/001970 WO1997030981A1 (fr) 1996-02-26 1997-02-18 Antimicrobiens a base d'azolyl piperazinyl phenyl oxazolidone

Publications (1)

Publication Number Publication Date
DK0883611T3 true DK0883611T3 (da) 2002-12-02

Family

ID=21754387

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97907574T DK0883611T3 (da) 1996-02-26 1997-02-18 Azolylpiperazinylphenyloxazolidinoner som antimikrobielle midler

Country Status (18)

Country Link
US (1) US5736545A (fr)
EP (1) EP0883611B1 (fr)
JP (1) JP2000505084A (fr)
KR (1) KR19990087238A (fr)
CN (1) CN1082952C (fr)
AT (1) ATE221521T1 (fr)
AU (1) AU703831B2 (fr)
DE (1) DE69714418T2 (fr)
DK (1) DK0883611T3 (fr)
ES (1) ES2180945T3 (fr)
ID (1) ID18467A (fr)
MY (1) MY116093A (fr)
NZ (1) NZ331011A (fr)
PE (1) PE55898A1 (fr)
PT (1) PT883611E (fr)
TW (1) TW442460B (fr)
WO (1) WO1997030981A1 (fr)
ZA (1) ZA971287B (fr)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9601666D0 (en) * 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds
GB9702213D0 (en) * 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
GB9609919D0 (en) * 1996-05-11 1996-07-17 Zeneca Ltd Chemical compounds
KR20010021645A (ko) * 1997-07-11 2001-03-15 로렌스 티. 마이젠헬더 티아디아졸릴 및 옥사디아졸릴 페닐 옥사졸리디논 항균제
GB9717807D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
GB9717804D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
GB9725244D0 (en) 1997-11-29 1998-01-28 Zeneca Ltd Chemical compounds
US7002020B1 (en) 1998-01-23 2006-02-21 Pharmacia & Upjohn Company Oxazolidinone combinatorial libraries, compositions and methods of preparation
BR9907183A (pt) * 1998-01-23 2003-06-10 Versicor Inc Colet neas combinatórias de oxazolidinona, composições e processos de preparação
US6562844B2 (en) 1998-01-23 2003-05-13 Pharmacia & Upjohn Company Oxazolidinone combinatorial libraries, compositions and methods of preparation
WO1999064417A2 (fr) 1998-06-05 1999-12-16 Astrazeneca Ab Composes chimiques
US6689372B1 (en) * 1998-08-04 2004-02-10 Ciba Specialty Chemicals Corporation Microbicidal active substances
EP1147422A1 (fr) 1999-01-27 2001-10-24 Pharmacia & Upjohn Company Dosages de modulateurs de l'activite du facteur d'elongation p
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
PE20010851A1 (es) * 1999-12-14 2001-08-17 Upjohn Co Esteres del acido benzoico de oxazolidinonas que tienen un substituyente hidroxiacetilpiperazina
GB0009803D0 (en) * 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
WO2003008389A1 (fr) * 2001-07-16 2003-01-30 Ranbaxy Laboratories Limited Derives d'oxazolidinone utilises comme antimicrobiens potentiels
HUP0302918A2 (hu) * 2000-07-17 2003-12-29 Ranbaxy Laboratories Limited Mikrobaellenes oxazolidinonszármazékok és a vegyületeket tartalmazó gyógyászati készítmények és eljárás a vegyületek előállítására
ATE304536T1 (de) * 2001-04-17 2005-09-15 Merck & Co Inc Bicyclo(3,1,0)hexan als strukturelement enthaltende oxazolidinon-antibiotika und deren derivate
JP2005529924A (ja) * 2002-05-15 2005-10-06 ランバクシー ラボラトリーズ リミテッド フェニルオキサゾリジノン誘導体
BR0215921A (pt) * 2002-07-29 2005-09-13 Ranbaxy Lab Ltd Derivados de oxazolidinona utilizáveis como antimicrobianos e processo de sua preparação
DE60304360T2 (de) 2002-08-12 2006-11-16 Pharmacia & Upjohn Co. Llc, Kalamazoo N-aryl-2-oxazolidinone und deren derivate
WO2004026848A1 (fr) * 2002-09-20 2004-04-01 Lupin Limited Derives d'oxazolidinone, leur procede de preparation et leur utilisation comme agents antimycobacterients
ATE344036T1 (de) 2002-11-21 2006-11-15 Pharmacia & Upjohn Co Llc N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinon-5- carbonsäureamid-derivate und verwandte verbindungen als antibakterielle mittel
CA2529292A1 (fr) * 2003-07-02 2005-01-20 Merck & Co., Inc. Antibiotiques a base d'oxazolidinone et derives
ATE471937T1 (de) * 2003-07-02 2010-07-15 Merck Sharp & Dohme Cyclopropylgruppensubstituierte oxazolidinonantibiotika und derivate davon
US20070185132A1 (en) * 2003-07-02 2007-08-09 Yasumichi Fukuda Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereo
AU2004256086B2 (en) * 2003-07-02 2007-12-06 Kyorin Pharmaceutical Co., Ltd. Oxazolidinone antibiotics and derivatives thereof
WO2005051933A1 (fr) * 2003-11-28 2005-06-09 Ranbaxy Laboratories Limited Procede ameliore de synthese d'ester test-butylique d'acide 4-(4-benzyloxy-carbonylamino-2-fluorophenyl)-piperazine-1-carboxylique, compose intermediaire cle de la preparation d'agents antimicrobiens a l'oxazolidinone, et composes ainsi prepares
WO2005082899A1 (fr) * 2004-01-28 2005-09-09 Ranbaxy Laboratories Limited Derives d'oxazolidinones utilises en tant qu'antimicrobiens
BRPI0510394A (pt) * 2004-05-24 2007-11-13 Amgen Inc inibidores de 11-beta-hidroxiesteróide desidrogenase tipo 1
US8686011B2 (en) 2004-05-24 2014-04-01 Amgen Inc. Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
WO2006035283A1 (fr) * 2004-09-27 2006-04-06 Ranbaxy Laboratories Limited Derives d'oxazolidinone a activite antimicrobienne
WO2006043121A1 (fr) * 2004-10-20 2006-04-27 Ranbaxy Laboratories Limited Derives d'oxazolidinone servant d'antimicrobiens
WO2006051408A1 (fr) * 2004-11-11 2006-05-18 Ranbaxy Laboratories Limited Derives d'oxazolidinone comme antimicrobiens
WO2007023507A2 (fr) * 2005-06-20 2007-03-01 Wockhardt Limited Composition a activite antimicrobienne supportant des oxazolidinones ainsi que procedes de preparation associes
JO2769B1 (en) * 2005-10-26 2014-03-15 جانسين فارماسوتيكا ان. في Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor
CN100406455C (zh) * 2006-02-20 2008-07-30 中国科学院上海药物研究所 含三氮唑基的噁唑烷酮类化合物及其制备方法和用途
JO2642B1 (en) * 2006-12-08 2012-06-17 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
JO2849B1 (en) * 2007-02-13 2015-03-15 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
US20100137368A1 (en) * 2007-04-23 2010-06-03 Janssen Pharmaceutica N.V. Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists
MX2009011416A (es) * 2007-04-23 2009-11-05 Janssen Pharmaceutica Nv Tia(di)azoles como antagonistas del receptor de dopamina 2 de disociacion rapida.
RS52518B (sr) * 2007-04-23 2013-04-30 Janssen Pharmaceutica N.V. Derivati 4-alkoksipiridazina kao brzo disocirajući dopamin 2 receptorski antagonisti
JP5613656B2 (ja) * 2008-03-26 2014-10-29 グローバル、アライアンス、フォア、ティービー、ドラッグ、ディベロップメント 置換されたフェニルオキサゾリジノンと共有結合した二環式ニトロイミダゾール
CA2729313C (fr) * 2008-07-03 2016-08-30 Janssen Pharmaceutica Nv 6-(1-piperazinyl)-pyridazines substituees comme antagonistes du recepteur 5-ht<sb>6</sb>
ES2622161T3 (es) * 2008-07-31 2017-07-05 Janssen Pharmaceutica, N.V. Piridinas sustituidas con piperazin-1-il-trifluorometilo como antagonistas del receptor de la dopamina 2 de disociación rápida
WO2011152442A1 (fr) * 2010-06-03 2011-12-08 塩野義製薬株式会社 Procédé de production de 2‑chloro-6-fluorobenzoxazole
CN102079730B (zh) * 2010-09-06 2013-10-16 贵州大学 一类含2,5-取代杂环基砜类衍生物及其合成方法和应用
CN103450173B (zh) * 2013-09-07 2015-06-03 吉首大学 吡咯酮-苯基-噁唑烷酮型化合物及其制法和用途
CN103709119B (zh) * 2013-12-04 2015-05-20 上海应用技术学院 一种制备5-氨基噻唑-4-甲酰胺的方法
CN104202835A (zh) * 2014-09-03 2014-12-10 苏州微站通信科技有限公司 Ue进入静默期时让基站及时释放时频资源的方法
ES2968678T3 (es) 2018-04-27 2024-05-13 Univ Osaka Inhibidores del canal TRPC3 o TRPC6
US12479816B2 (en) 2019-02-08 2025-11-25 University of Pittsburgh—of the Commonwealth System of Higher Education 20-HETE formation inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801600A (en) * 1987-10-09 1989-01-31 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US4921869A (en) * 1987-10-09 1990-05-01 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US4977173A (en) * 1987-10-21 1990-12-11 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl ethenylbenzene derivatives useful as antibacterial agents
US5254577A (en) * 1988-07-29 1993-10-19 The Du Pont Merck Pharmaceutical Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
US4948801A (en) * 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
MY115155A (en) * 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
CA2174107C (fr) * 1993-11-22 2005-04-12 Steven J. Brickner Esters de derives de substitution d'hydroxyacetyl-piperazinyl-phenyl-oxazolidinones

Also Published As

Publication number Publication date
DE69714418T2 (de) 2003-01-16
MY116093A (en) 2003-11-28
JP2000505084A (ja) 2000-04-25
TW442460B (en) 2001-06-23
KR19990087238A (ko) 1999-12-15
US5736545A (en) 1998-04-07
WO1997030981A1 (fr) 1997-08-28
ES2180945T3 (es) 2003-02-16
ID18467A (id) 1998-04-09
EP0883611A1 (fr) 1998-12-16
NZ331011A (en) 2000-04-28
CN1206410A (zh) 1999-01-27
EP0883611B1 (fr) 2002-07-31
PT883611E (pt) 2002-12-31
AU1954797A (en) 1997-09-10
ZA971287B (en) 1998-08-14
DE69714418D1 (de) 2002-09-05
HK1017033A1 (en) 1999-11-12
PE55898A1 (es) 1998-09-16
AU703831B2 (en) 1999-04-01
CN1082952C (zh) 2002-04-17
ATE221521T1 (de) 2002-08-15

Similar Documents

Publication Publication Date Title
DK0883611T3 (da) Azolylpiperazinylphenyloxazolidinoner som antimikrobielle midler
SE9904176D0 (sv) New use
SE9903760D0 (sv) New compounds
DK0951474T3 (da) Nye cyclosporinderivater, deres fremstilling og farmaceutiske præparater deraf
HUP0101999A2 (hu) 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
DK0948527T3 (da) Cylosporinderivater, fremstilling af disse og farmaceutiske præparater indeholdende disse
NO996108L (no) 9-oksinerytromycinderivater
DZ1694A1 (fr) &#34;n-(2-Aminoethyl)-benzothialozones&#34;.
DK1030852T3 (da) Oxazolidinonderivater og farmaceutiske præparater
DK0665834T3 (da) Quinolon- og acridinonderivater til behandling af urininkontinens
AU8156394A (en) Methods for inhibiting LDL oxidation and atheroclerosis
UA27910C2 (uk) Засіб для підвищення експресії тромбомодуліну та підвищення активації протеїну с
ATE170852T1 (de) Benzolsulfonamid-derivate zur behandlung der blaseninstabilität
WO1995001170A3 (fr) Utilisation des derives de phenethanolamine dans le traitement des troubles gastro-intestinaux
DK0583271T3 (da) Arylmorpholin, fremstilling og anvendelse
NO944407D0 (no) Alkoholer som kalium-kanalåpnere og ved behandling av urin-inkontinens
AU568996B2 (en) Heptanoyl-glu-asp-ala-amino acid immunostimulants
MX9804828A (es) Benzotiazolona etanaminas biologicamente activas.
WO2003024941A1 (fr) Composes de naphtalene et leur utilisation comme medicament
CA2243706A1 (fr) Antimicrobiens a base d&#39;azolyl piperazinyl phenyl oxazolidone
SE9603284D0 (sv) New compounds
DE69923117D1 (de) Verwendung von Homocysteinderivaten zur Behandlung von bakteriellen Infektionen
ECSP972035A (es) Antimicrobianos de azolilpiperazinilfe loxazolidinona